The approval of Niktimvo in graft-versus-host disease hands Incyte another immune system-regulating medicine that analysts see as valuable, especially if use is broadened through additional clearances.
Read more about this post on BioPharmaDive
Trending
- Natural Cervical Ripening to Prevent Pharmacological Induction of Labor – a Pilot Study.
- Combined rTMS and tSCS for Upper Limb Recovery in Cervical SCI
- Comparison of the Italian and U.S. Forensic Models for Dual-diagnosis Offenders: a 3-year Longitudinal Study
- Celebrating the Class of 2026: Spring Commencement at the College of Medicine and Life Sciences
- Enhancing Strategic Academic Ties Between Indonesia and Turkiye
- Regeneron Partners with Parabilis to Propel Innovative Antibody-Helicon Conjugates in Diverse Therapies
- Mastering Job Offer Negotiation in Biotech
- Shareholder Support for Incentive Plan Boosts Ultragenyx Potential
Incyte builds out its arsenal of post-transplant drugs
By Jacob Bell